Disease-specific overall survival in endometrioid ovarian

Treatment Patterns and Outcomes Among Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States

Diagnostics, Free Full-Text

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial - The Lancet Oncology

Pretreatment with LCK Inhibitors Chemosensitizes Cisplatin-Resistant Endometrioid Ovarian Tumors

Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease- Specific Death - Modern Pathology

Clinical factors associated with prognosis in low-grade serous ovarian carcinoma: experiences at two large academic institutions in Korea and Taiwan

Characterization of ovarian cancer survival by histotype and stage: A nationwide study in Norway - Fortner - 2023 - International Journal of Cancer - Wiley Online Library

Diagnostics, Free Full-Text

Olaparib maintenance for first-line treatment of ovarian cancer: will SOLO1 reset the standard of care?

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study - The Lancet Oncology

Patient-initiated follow-up after treatment for low risk endometrial cancer: a prospective audit of outcomes and cost benefits